Tyra Biosciences, Inc.
TYRANASDAQHealthcare● Active
$26.75
+$0.11(+0.41%)
Market Cap$1.6B
P/E Ratio—
52W High$40.65
52W Low$8.98
Tyra Biosciences, Inc. (TYRA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
TYRA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.64
Est. -$0.60 · -6.7%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▼ Miss EPS
TYRA reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.68 | — | — | — | — | — |
| ▼ Q2 FY2026 | May 13, 2026 | -$0.60 | -$0.64 | -6.7% | — | — | — |
| ▼ Q1 FY2026 | Mar 2, 2026 | -$0.54 | -$0.57 | -5.6% | — | — | — |
| — Q4 FY2025 | Nov 5, 2025 | -$0.50 | -$0.50 | +0.0% | — | — | — |
| ▲ Q3 FY2025 | Aug 14, 2025 | -$0.53 | -$0.47 | +11.3% | — | — | — |
| ▲ Q2 FY2025 | May 8, 2025 | -$0.49 | -$0.47 | +4.1% | — | — | — |
| ▲ Q1 FY2025 | Mar 27, 2025 | -$0.48 | -$0.43 | +10.4% | — | — | — |
| ▼ Q4 FY2024 | Nov 7, 2024 | -$0.40 | -$0.41 | -2.5% | — | — | — |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.68
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Miss
EPS Actual
-$0.64
EPS Est.
-$0.60
EPS Surpr.
-6.7%
Revenue
—
Q1 FY2026
Mar 2, 2026Miss
EPS Actual
-$0.57
EPS Est.
-$0.54
EPS Surpr.
-5.6%
Revenue
—
Q4 FY2025
Nov 5, 2025
EPS Actual
-$0.50
EPS Est.
-$0.50
EPS Surpr.
+0.0%
Revenue
—
Q3 FY2025
Aug 14, 2025Beat
EPS Actual
-$0.47
EPS Est.
-$0.53
EPS Surpr.
+11.3%
Revenue
—
Q2 FY2025
May 8, 2025Beat
EPS Actual
-$0.47
EPS Est.
-$0.49
EPS Surpr.
+4.1%
Revenue
—
Q1 FY2025
Mar 27, 2025Beat
EPS Actual
-$0.43
EPS Est.
-$0.48
EPS Surpr.
+10.4%
Revenue
—
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
-$0.41
EPS Est.
-$0.40
EPS Surpr.
-2.5%
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.87 | $-0.87 | $-0.87 | 5 |
| Q3 FY2028 | $-0.86 | $-0.86 | $-0.86 | 5 |
| Q2 FY2028 | $-0.86 | $-0.86 | $-0.86 | 5 |
| Q1 FY2028 | $-0.84 | $-0.84 | $-0.84 | 5 |
| Q4 FY2027 | $-0.82 | $-0.82 | $-0.82 | 4 |
| Q3 FY2027 | $-0.77 | $-0.77 | $-0.77 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 13, 2026 | -6.7% | $34.87 | $36.19 | +3.79% |
| ▼ Q1 FY2026 | Mar 2, 2026 | -5.6% | $33.31 | $32.52 | -2.37% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +0.0% | $15.00 | $14.82 | -1.20% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +11.3% | $10.75 | $10.70 | -0.47% |
| ▲ Q2 FY2025 | May 8, 2025 | +4.1% | $9.13 | $10.07 | +10.30% |
| ▲ Q1 FY2025 | Mar 27, 2025 | +10.4% | $10.24 | $9.66 | -5.66% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -2.5% | $17.12 | $17.15 | +0.18% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +21.9% | $20.20 | $19.50 | -3.47% |
Q2 FY2026+3.79%
Report Date
May 13, 2026
EPS Beat/Miss
-6.7%
Price Before
$34.87
Price After
$36.19
Q1 FY2026-2.37%
Report Date
Mar 2, 2026
EPS Beat/Miss
-5.6%
Price Before
$33.31
Price After
$32.52
Q4 FY2025-1.20%
Report Date
Nov 5, 2025
EPS Beat/Miss
+0.0%
Price Before
$15.00
Price After
$14.82
Q3 FY2025-0.47%
Report Date
Aug 14, 2025
EPS Beat/Miss
+11.3%
Price Before
$10.75
Price After
$10.70
Q2 FY2025+10.30%
Report Date
May 8, 2025
EPS Beat/Miss
+4.1%
Price Before
$9.13
Price After
$10.07
Q1 FY2025-5.66%
Report Date
Mar 27, 2025
EPS Beat/Miss
+10.4%
Price Before
$10.24
Price After
$9.66
Q4 FY2024+0.18%
Report Date
Nov 7, 2024
EPS Beat/Miss
-2.5%
Price Before
$17.12
Price After
$17.15
Q3 FY2024-3.47%
Report Date
Aug 7, 2024
EPS Beat/Miss
+21.9%
Price Before
$20.20
Price After
$19.50
Avg Beat Reaction-0.10%
Avg Miss Reaction+0.53%
Beat Rate5 / 8 quarters
Largest Move+10.30% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: TYRA ends December
Tyra Biosciences, Inc. (TYRA) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.64 — missing the analyst consensus of $-0.60 by -6.7%. The next TYRA earnings date is expected around September 1, 2026.
Each quarter, investors track TYRA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. TYRA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
TYRA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
TYRA earnings · 5 questionsTyra Biosciences, Inc.'s next earnings report is expected around September 1, 2026. TYRA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; TYRA historically reports after market close (AMC).
TYRA earnings datewhen is TYRA earningsTYRA next earnings datewhen does TYRA report earningsTYRA earnings calendar
▸ Source: FMP · Tyra Biosciences, Inc. SEC filings · US GAAP · Tyra Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026